10.49
-0.29%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Hunan Jiudian Pharmaceutical Co
Its shares trade on Shenzhen under the ticker 300705.SZ. It has been listed since 10 October 2017. In the fiscal year to 31 December 2025, it reported revenue of CN¥3.11bn and net income of CN¥472.8m. At that date it held total assets of CN¥4.02bn and shareholders' equity of CN¥2.66bn.
Hunan Jiudian Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company is headquartered in Changsha, Hunan. The company went IPO on 2017-10-10. The Company’s products are comprised of pharmaceutical preparations, raw materials, pharmaceutical excipients and plant extracts, including loxoprofen sodium gel ointment, ornidazole raw materials and preparations, dirithromycin raw materials and preparations, clindamycin phosphate tablets and so on. The products are used for the treatment of bacterial infections and anti-allergy. The firm sells its products to both domestic and international markets, including Europe, South Korea, India, Russia and South America.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 10 Oct 2017
- Employees
- 1,636
- Website
- hnjiudian.com ↗
Leadership
Pay as last reported
- Mr. Zhihong ZhuChairman of the Board, since 2015CN¥962,200
- Ms. Ying XiongChief Financial OfficerCN¥621,700
- Mr. Yang YangGeneral Manager, Director, since 2015CN¥999,900
- Ms. Lei ZengDeputy General Manager, Secretary of the BoardCN¥439,500
- Mr. Pengyun FanDeputy General Manager, Director, since 2024
- Mr. Ying LiuDeputy General ManagerCN¥714,800
- Ms. Zhiyun ZhuChief Supply Officer, Director, since 2015CN¥679,200
- Ms. Jing XiangIndependent DirectorCN¥57,500
- Ms. Qiulin YangIndependent DirectorCN¥57,500
- Mr. Congshan ZhouIndependent DirectorCN¥57,500
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Hunan Jiudian Pharmaceutical employs 1,636 full-time employees in Changsha, CN.
- The company produces loxoprofen sodium gel ointment for bacterial infections and anti-allergy treatments.
- Hunan Jiudian sells pharmaceutical products to Europe, South Korea, India, and Russia markets.
Weaknesses
- The company's products include ornidazole raw materials and preparations for bacterial infections.
- Hunan Jiudian's business relies on pharmaceutical excipients and plant extracts.
- The firm's sales are limited to Europe, South Korea, India, and Russia markets.
Opportunities
- Hunan Jiudian can expand into South America for pharmaceutical sales.
- The company can develop new pharmaceutical preparations for anti-allergy treatments.
- Hunan Jiudian may increase production of dirithromycin raw materials.
Threats
- Hunan Jiudian faces competition from European pharmaceutical firms.
- The company's reliance on raw materials may lead to supply chain issues.
- Hunan Jiudian must navigate international trade regulations in South Korea and India.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.